Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep 27:15:1496367.
doi: 10.3389/fgene.2024.1496367. eCollection 2024.

Editorial: Personalized therapies for monogenic diabetes

Maurizio Delvecchio  1 , Ming Liu  2 , Novella Rapini  3 , Fabrizio Barbetti  4
Affiliations
Editorial

Editorial: Personalized therapies for monogenic diabetes

Maurizio Delvecchio et al. Front Genet. .
No abstract available

Keywords: MODY; Mendelian randomization; Rabson-Mendenhall syndrome; gestational diabetes; monogenic diabetes; neonatal diabetes mellitus; personalized medicine; severe insulin resistance syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Personalized therapies for monogenic diabetes

References

    1. Bowman P., Mathews F., Barbetti F., Shepherd M. H., Sanchez J., Piccini B., et al. (2021). Long-term follow-up of glycemic and neurological outcomes in an international series of patients with sulfonylurea-treated ABCC8 permanent neonatal diabetes. Diabetes Care 44 (1), 35–42. 10.2337/dc20-1520 - DOI - PMC - PubMed
    1. Bowman P., Sulen Å., Barbetti F., Beltrand J., Svalastoga P., Codner E., et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol. 2018;6(8):637–646. Erratum in: Lancet Diabetes Endocrinol. 2018;6(9):e17. 10.1016/S2213-8587(18)30238-9 10.1016/S2213-8587(18)30106-2 - DOI - PMC - PubMed
    1. Colclough K., Ellard S., Hattersley A., Patel K. (2022). Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of maturity-onset diabetes of the young. Diabetes 71, 530–537. 10.2337/db21-0517 - DOI - PMC - PubMed
    1. Delvecchio M., Pastore C., Giordano P. (2020). Treatment options for MODY patients: a systematic review of literature. Diabetes Ther. 11 (8), 1667–1685. 10.1007/s13300-020-00864-4 - DOI - PMC - PubMed
    1. Naylor R. N., Patel K. A., Kettunen J. L. T., Männistö J. M. E., Støy J., Beltrand J., et al. (2024). Precision treatment of beta-cell monogenic diabetes: a systematic review. Commun. Med. (Lond). 4 (1), 145. 10.1038/s43856-024-00556-1 - DOI - PMC - PubMed

Publication types

LinkOut - more resources